{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:45:10Z","timestamp":1713314710561},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,15]]},"DOI":"10.7759\/cureus.58356","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:05:41Z","timestamp":1713247541000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Corneal Thinning During S-1 Oral Administration"],"prefix":"10.7759","author":[{"given":"Ayaka","family":"Shimada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Ichioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Harano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tanito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-015-0421-1","article-title":"Predictive factors for ocular complications caused by anticancer drug S-1","volume":"60","author":"Yamada R","year":"2016","unstructured":"Yamada R, Sotozono C, Nakamura T, et al.. Predictive factors for ocular complications caused by anticancer drug S-1. Japan J Ophthalmol. 2016, 60:63-71. 10.1007\/s10384-015-0421-1","journal-title":"Japan J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/1874364101307010085","article-title":"Adverse effects of the oral anticancer drug s-1: lacrimal passage impairment and specific features of corneal epitheliopathy","volume":"7","author":"Sato K","year":"2013","unstructured":"Sato K, Nishimura S. Adverse effects of the oral anticancer drug s-1: lacrimal passage impairment and specific features of corneal epitheliopathy. Open Ophthalmol J. 2013, 7:85-6. 10.2174\/1874364101307010085","journal-title":"Open Ophthalmol J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/07357909009012068","article-title":"Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity","volume":"8","author":"Loprinzi CL","year":"1990","unstructured":"Loprinzi CL, Love RR, Garrity JA, Ames MM. Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity. Cancer Invest. 1990, 8:459-65. 10.3109\/07357909009012068","journal-title":"Cancer Invest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S71102","article-title":"Surgical therapies for corneal perforations: 10 years of cases in a tertiary referral hospital","volume":"8","author":"Yokogawa H","year":"2014","unstructured":"Yokogawa H, Kobayashi A, Yamazaki N, Masaki T, Sugiyama K. Surgical therapies for corneal perforations: 10 years of cases in a tertiary referral hospital. Clin Ophthalmol. 2014, 8:2165-70. 10.2147\/OPTH.S71102","journal-title":"Clin Ophthalmol"},{"key":"ref5","article-title":"Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1","volume":"15","author":"Chikama T","year":"2009","unstructured":"Chikama T, Takahashi N, Wakuta M, Nishida T. Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1. Mol Vis. 2009, 15:2896-904.","journal-title":"Mol Vis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2020.03.018","article-title":"Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: report of three cases","volume":"44","author":"Bauters G","year":"2021","unstructured":"Bauters G, Paques M, Borderie V, Bouheraoua N. Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: report of three cases. J Fr Ophtalmol. 2021, 44:67-75. 10.1016\/j.jfo.2020.03.018","journal-title":"J Fr Ophtalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/245106-a-case-of-corneal-thinning-during-s-1-oral-administration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:05:44Z","timestamp":1713247544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/245106-a-case-of-corneal-thinning-during-s-1-oral-administration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.58356","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}